A Long-Term Prevention Study with Oxprenolol in Coronary Heart Disease

New England Journal of Medicine

Volumn 307, Issue 21, 1982, Pages 1293-1301

  Taylor, S H ^a   Silke, B ^a   Ebbutt, A ^a   Sutton, G C ^a   Prout, B J ^a   Burley, D M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OXPRENOLOL;

ADVERSE DRUG REACTION; BRONCHOSPASM; CLINICAL TRIAL; COLD LIMB; CONTROLLED STUDY; DYSPNEA; EYE TOXICITY; FATIGUE; HEART; HEART INFARCTION; HEART PALPITATION; HEART REINFARCTION; HUMAN; HYPOTENSION; INTOXICATION; ISCHEMIC HEART DISEASE; MENTAL DISEASE; ORAL DRUG ADMINISTRATION; PREVENTION; PREVENTIVE MEDICINE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYSTEM; SKIN TOXICITY; SLEEP DISORDER; THERAPY; VISUAL SYSTEM;

EID: 0019919373     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198211183072101     Document Type: Article

References (34)

1. Sonnenblick E.H., Ross J. Jr., Covell J.W., Kaiser G.A., Braunwald E. Velocity of contraction as a determinant of myocardial oxygen consumption. Am J Physiol. 1965; 209:919-927
2. Maroko P.R., Kjekshus J.K., Sobel B.E., et al. Factors influencing infarct size following experimental coronary artery occlusions. Circulation. 1971; 43:67-82.
3. Gibson D., Sowton E. The use of beta-adrenergic receptor blocking drugs in dysrhythmias. Prog Cardiovasc Dis. 1969; 12:16-39.
4. Snow P.J.D. Effect of propranolol in myocardial infarction. Lancet. 1965; 2:551-553
5. Stephen S.A. Propranolol in acute myocardial infarction: a multicentre trial. Lancet. 1966; 2:1435-1438
6. Balcon R., Jewitt D.E., Davies J.P.H., Oram S. A controlled trial of propranolol in acute myocardial infarction. Lancet. 1966; 2:917-920
7. Clausen J., Felsby M., Jørgensen F.S., Nielsen B.L., Roin J., Strange B. Absence of prophylactic effect of propranolol in myocardial infarction. Lancet. 1966; 2:920-924
8. Norris R.M., Caughey D.E., Scott P.J. Trial of propranolol in acute myocardial infarction. Br Med J. 1968; 2:398-400.
9. Taylor S.H., Meeran M.K. Different effects of adrenergic beta-receptor blockade on the heart rate response to mental stress, catecholamines, and exercise. Br Med J. 1973; 4:257-259
10. Lovell R.R.H. Problems of interpretation in secondary prevention trials in coronary heart disease. Med J Aust. 1977; 1:224-226
11. Mitchell J.R.A. Secondary prevention of myocardial infarction — the present state of the ART. Br Med J. 1980; 280:1128-1130
12. Ischaemic heart disease register. Copenhagen: World Health Organization. 1971.
13. Jack D.B., Riess W. Determination of low levels of oxprenolol in blood or plasma by gas-liquid chromatography. J Chromatogr. 1974; 88:173-176
14. Jack D.B., Dean S., Kendal M.J. Detection of some antihypertensive drugs and their metabolites in urine by thin layer chromatography: five commonly used beta blockers and hydralazine. J Chromatogr. 1980; 187:277-280
15. Mace A.E. Sample size determination. New York: Reinhold, 1964: 101-4.
16. Rose G.A., Blackburn H. Cardiovascular survey methods. WHO monograph series. 1968; 56:137-174
17. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53:457-481
18. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. JNCI. 1959; 22:719-748
19. Norwegian Multicentre Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981; 304:801-807
20. Hjalmarson A., Elmfeldt D., Herlitz J., et al. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial. Lancet. 1981; 2:823-827
21. β-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA. 1982; 247:1707-1714
22. Alderman E.L., Coltart D.J., Wettach G.E., Harrison D.C. Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med. 1974; 81:625-627
23. Wilhelmsson C., Vedin J.A., Wilhelmsen L., Tibblin G., Werköl L. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet. 1974; 2:1157-1160
24. Multicentre International Study. Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade: multicentre international study: supplementary report. Br Med J. 1977; 2:419-421
25. Anderson M.P., Bechsgaard P., Frederiksen J., et al. Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction: preliminary results. Lancet. 1979; 2:865-868
26. Baber N.S., Evans D.W., Howitt G., et al. Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia. Br Heart J. 1980; 44:96-100.
27. Hansteen V., Møinichen E., Lorentsen E., et al. One year#x0027;s treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Br Med J. 1982; 284:155-160
28. Helgeland A., Hjermann I., Leren P., Enger S., Holme I. High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study. Br Med J. 1978; 2:403-404
29. Freiman J.A., Chalmers T.C., Smith H. Jr., Kuebler R.R. The importance of beta, the Type II error and sample size in the design and interpretation of the randomized control trial: survey of 71 “negative” trials. N Engl J Med. 1978; 299:690-694
30. Yusuf S., Ramsdale D., Peto R., et al. Early intravenous atenolol treatment in suspected acute myocardial infarction: preliminary report of a randomised trial. Lancet. 1980; 2:273-276
31. Hampton J.R. The use of beta-blockers for the reduction of mortality after myocardial infarction. Eur Heart J. 1981; 12:259-268
32. Wilcox R.G., Roland J.M., Banks D.C., Hampton J.R., Mitchell J.R.A. Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J. 1980; 280:885-888
33. Wilcox R.G., Rowley J.M., Hampton J.R., Mitchell J.R.A., Rowland J.M., Banks D.C. Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet. 1980; 2:765-769
34. Coronary Prevention Research Group. An early intervention secondary prevention study with oxprenolol following myocardial infarction. Eur Heart J. 1981; 12:389-393